Clinical Evaluation of a Myopia Control Lens in Slowing Myopia Progression (CSL)
Myopia
About this trial
This is an interventional treatment trial for Myopia focused on measuring refractive error, eye disease
Eligibility Criteria
Inclusion Criteria: Volunteer subject and guardian, fluent English spoken, willing to follow protocol and able to read, comprehend and sign the informed consent & assent form. 8 to 13 years old at time of informed consent and assent. Spherical equivalent refractive error (SER) by manifest refraction between -0.75 and -4.75 D in each eye. Astigmatism, if present, of not more than 1.50 D. Difference in SER between the two eyes (Anisometropia) by manifest refraction not more than 1.00 D. Best corrected visual acuity in each eye equal to or better than +0.10 logMAR (≥ 20/25 as Snellen) Be in good general health based on his/her and parent's/guardian's knowledge. Absence of ocular disease with full ophthalmic examination. Without any ocular or systemic condition known to affect refractive status. Absence of strabismus by cover test at near or distance wearing correction. Absence of amblyopia Without ocular or systemic medications which, in the investigator's opinion, may significantly affect pupil size, accommodation or refractive state. Exclusion Criteria: Vulnerability of subject History of myopia control intervention Participation in any clinical study within 30 days of the Baseline visit.
Sites / Locations
- Essilor R&D Centre Singapore
Arms of the Study
Arm 1
Experimental
Test myopia control lenses (CSL)
A pair of myopia control spectacle lenses (test lenses) will be given to subjects to wear for 12 months